GreenSignal Bio Pharma IPO is a book build issue .
GreenSignal Bio Pharma IPO bidding started from Nov 9, 2016 and ended on Nov 22, 2016. The allotment for GreenSignal Bio Pharma IPO was finalized on Nov 18, 2016. GreenSignal Bio Pharma IPO will list on BSE, NSE with a tentative listing date fixed as Nov 22, 2016.
GreenSignal Bio Pharma IPO price band is set at ₹68.00 to ₹76.00 per share . The lot size for an application is 175. The minimum amount of investment required by an retail is ₹11,900 (175 shares). The lot size investment for sNII is 16 lots (2,800 shares), amounting to ₹2,12,800, and for bNII, it is 76 lots (13,300 shares), amounting to ₹10,10,800.
Indian Overseas Bank is the book running lead manager and Bigshare Services Pvt.Ltd. is the registrar of the issue.
Refer to GreenSignal Bio Pharma IPO RHP for detailed Information.
IPO Date | November 9, 2016 to November 22, 2016 |
Listing Date | [.] |
Face Value | ₹10 per share |
Issue Price Band | ₹68 to ₹76 per share |
Lot Size | 175 Shares |
Sale Type | Offer For Sale |
Issue Type | Bookbuilding IPO |
Listing At | BSE, NSE |
GreenSignal Bio Pharma IPO offers 14,579,560 shares. 10,934,670 (75.00%) to QIB, 2,186,934 (15.00%) to NII, 1,457,956 (10.00%) to RII. 8,331 RIIs will receive minimum 175 shares and (sNII) and (bNII) will receive minimum 2,800 shares. (in case of oversubscription)
Investor Category | Shares Offered | Maximum Allottees |
---|---|---|
Anchor Investor Shares Offered | - | NA |
QIB Shares Offered | 10,934,670 (75.00%) | NA |
NII (HNI) Shares Offered | 2,186,934 (15.00%) | |
Retail Shares Offered | 1,457,956 (10.00%) | 8,331 |
Total Shares Offered | 14,579,560 (100%) |
GreenSignal Bio Pharma IPO opens on November 9, 2016, and closes on November 22, 2016.
IPO Open Date | Wed, Nov 9, 2016 |
IPO Close Date | Tue, Nov 22, 2016 |
Tentative Allotment | Fri, Nov 18, 2016 |
Initiation of Refunds | Mon, Nov 21, 2016 |
Credit of Shares to Demat | Mon, Nov 21, 2016 |
Tentative Listing Date | Tue, Nov 22, 2016 |
Cut-off time for UPI mandate confirmation | 5 PM on Tue, Nov 22, 2016 |
Investors can bid for a minimum of 175 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.
Application | Lots | Shares | Amount |
---|---|---|---|
Retail (Min) | 1 | 175 | ₹13,300 |
Retail (Max) | 15 | 2,625 | ₹1,99,500 |
S-HNI (Min) | 16 | 2,800 | ₹2,12,800 |
S-HNI (Max) | 75 | 13,125 | ₹9,97,500 |
B-HNI (Min) | 76 | 13,300 | ₹10,10,800 |
Incorporated in 2005, GreenSignal Bio Pharma is Chennai based pharmaceutical company engaged in the development, manufacture and sale of the BCG vaccine. source chittorgarh.com, India's No. 1 IPO Investment Portal. GreenSignal is an Indian vaccine manufacturing company with global operations. The products company manufacture includes a BCG vaccine and BCG-ONCO, an immunotherapy drug. The immunotherapy drug is used in the treatment of urinary bladder cancer.
Both vaccines produced by GreenSignal are generic drugs and company do not require any patents for the same.
GreenSignal has a long term contract with UNICEF to supply the BCG vaccine to UNICEF. GreenSignal is among 4 companies worldwide who have been WHO-prequalified to supply the BCG vaccine to UNICEF. Other customers include Indonesia, Nepal and Ministry of Health, India.
GreenSignal Pharma business is organized into domestic and international operations. For FY 2016, GreenSignal's domestic and international operations accounted for 53.79% and 46.20%, respectively, of its net revenues from operations. Visit chittorgarh.com for more detail.
GreenSignal Bio have a manufacturing facility located at Pappankuppam Village, Gummidipoondi, Tiruvallur District, Tamil Nadu.
Particulars | For the year/period ended (in Rs. Lacs) | |||||
---|---|---|---|---|---|---|
As at 30-Jun-16 | 31-Mar-16 | 31-Mar-15 | 31-Mar-14 | 31-Mar-13 | 31-Mar-12 | |
Total Assets | 7,099.80 | 6,934.17 | 5,866.98 | 5,694.50 | 5,387.48 | 5,718.08 |
Total Revenue | 1,020.55 | 2,049.25 | 660.29 | 352.80 | 1,169.80 | 1,126.58 |
Profit After Tax (PAT) | 293.09 | 530.95 | (21.33) | (129.71) | (50.01) | (48.11) |
[Dilip Davda] This Company will enjoy first mover advantage in the important generic vaccine sector and will attract fancy going forward. Moderate investment may be considered for long term rewards as the issue size is small and will attract T segment listing for initial period due to which, short term rewards unlikely. Read detail review...
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that according to 26 (2) of SEBI (ICDR) Regulations, if 75% of the net offer to public cannot be allotted to QIBs, the entire application money shall be refunded forthwith. Hence, the IPO of GreenSignal Bio Pharama Limited may be treated as withdrawn.
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been further extended upto 22 Nov,2016. Post issue modification date has been revised to 23 Nov,2016. Price band has been revised to Rs 68/- to Rs 76/-
Book Running Lead Managers to the GreenSignal Bio Pharma Limited, has informed the Exchange that the issue closure date has been extended upto 17 Nov,2016. Post issue modification date has been revised to 18 Nov,2016.
GreenSignal Bio Pharma Ltd.
13/A - 3 Sai Niketan Circular Road,
United India Colony,
Kodambakkam,
Chennai, Tamil Nadu, 600024
Phone: +91 44 2472 2244
Email: cs@gsbpl.com
Website: http://www.gsbpl.com
Bigshare Services Pvt.Ltd.
Phone: +91-22-6263 8200
Email: ipo@bigshareonline.com
Website: https://ipo.bigshareonline.com/IPO_Status.html
GreenSignal Bio Pharma IPO is a main-board IPO of 0 equity shares of the face value of ₹10 aggregating up to ₹[.] Crores. The issue is priced at . The minimum order quantity is 175.
The IPO opens on November 9, 2016, and closes on November 22, 2016.
Bigshare Services Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.
Zerodha customers can apply online in GreenSignal Bio Pharma IPO using UPI as a payment gateway. Zerodha customers can apply in GreenSignal Bio Pharma IPO by login into Zerodha Console (back office) and submitting an IPO application form.
Steps to apply in GreenSignal Bio Pharma IPO through Zerodha
Visit Zerodha IPO Application Process Review for more detail.
The GreenSignal Bio Pharma IPO opens on November 9, 2016 and closes on November 22, 2016.
GreenSignal Bio Pharma IPO lot size is 175, and the minimum amount required for application is ₹13,300.
You can apply in GreenSignal Bio Pharma IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO Application is offered by brokers who don't offer banking services. Read more detail about applying IPO online through Zerodha, Upstox, 5Paisa, Nuvama, HDFC Bank, and SBI Bank.
The finalization of Basis of Allotment for GreenSignal Bio Pharma IPO will be done on Friday, November 18, 2016, and the allotted shares will be credited to your demat account by Monday, November 21, 2016. Check the GreenSignal Bio Pharma IPO allotment status.
The GreenSignal Bio Pharma IPO listing date is not yet announced. The tentative date of GreenSignal Bio Pharma IPO listing is Tuesday, November 22, 2016.
Useful Articles